Piedmont Investment Advisors’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-274
Closed -$2K 2500
2018
Q2
$2K Buy
+274
New +$2K ﹤0.01% 2670